Impact of Coronary Microvascular Dysfunction on Patient-Reported Symptoms After PCI.

Saved in:
Bibliographic Details
Title: Impact of Coronary Microvascular Dysfunction on Patient-Reported Symptoms After PCI.
Authors: Bouisset F; Department of Cardiology Toulouse University Hospital, France., Ikeda K; Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan., Mizukami T; Division of Clinical Pharmacology, Department of Pharmacology, Showa University, Tokyo, Japan; Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium., Munhoz D; Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium., Sonck J; Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium., Sakai K; Department of Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo, Japan., Matsuo H; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan., Ando H; Department of Cardiology, Aichi Medical University, Aichi, Japan., Ko B; Monash Cardiovascular Research Centre, Monash University and Monash Heart, Monash Health, Clayton, Victoria, Australia., Biscaglia S; Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy., Rivero F; Cardiac Department, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain., Leone AM; Center of Excellence in Cardiovascular Sciences, Ospedale Isola Tiberina Gemelli Isola, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy., Yong A; Concord Repatriation General Hospital, University of Sydney, New South Wales, Australia., Escaned J; Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos and Complutense University, Madrid, Spain., Collison D; School Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom; NHS Golden Jubilee Hospital, Clydebank, United Kingdom., Campo G; Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy., Desta L; Department of Cardiology, Karolinska University Hospital, Solna, Stockholm, Sweden., Amano T; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan., Shinke T; Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium., Fearon WF; Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University School of Medicine and VA Palo Alto Health Care System, Palo Alto, California, USA., Korngold E; Abbott Vascular., Christiansen EH; Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark., Berry C; School Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom; NHS Golden Jubilee Hospital, Clydebank, United Kingdom., Perera D; School of Cardiovascular Medicine and Sciences, St Thomas' Hospital Campus, King's College London, London, United Kingdom., De Bruyne B; Division of Clinical Pharmacology, Department of Pharmacology, Showa University, Tokyo, Japan., Johnson NP; Weatherhead PET Center, Division of Cardiology, Department of Medicine, McGovern Medical School at UTHealth and Memorial Hermann Hospital, Houston, Texas, USA., Collet C; Clinical Trial Center, Cardiovascular Research Foundation, New York, New York, USA. Electronic address: carloscollet@gmail.com.
Source: JACC. Advances [JACC Adv] 2026 Jul 13; Vol. 5 (8), pp. 102946. Date of Electronic Publication: 2026 Jul 13.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv
Database: MEDLINE Ultimate
Description
ISSN:2772-963X
DOI:10.1016/j.jacadv.2026.102946